Not Yet Recruiting
Upadacitinib in Treatment of JAK/STAT Pathway Disorders With Activating Mutations
NCT07670156
- Conditions
- Immune System Diseases, Immunologic Deficiency Syndromes, JAK1 GOF, +4 more
- Locations
-
- Washington University in St.Louis St Louis, Missouri, United States
- Columbia University New York, United States
- Baylor College of Medicine Houston, Texas, United States